Elevation Oncology (NASDAQ:ELEV) just reported results for the fourth quarter of 2023.
- Elevation Oncology reported earnings per share of -19 cents. This was above the analyst estimate for EPS of -23 cents.
- The company did not report any revenue for the quarter.